MedTrace Logo

Effect of Adding Dexamethasone to Bupivacaine 0.25% in SCPB on Surgical Field Visibility During Tympanomastoid Surgery

NCT06416891 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-05-17

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of adding dexamethasone to bupivacaine 0.25% in ultrasound-guided SCPB on surgical field visibility during tympanomastoid surgery.

Conditions

  • Surgical Field
  • Postoperative Pain

Interventions

DRUG

bupivacaine 0.25%

SCPB using 10 ml of bupivacaine 0.25%

DRUG

dexamethasone 2 mg in bupivacaine 0.25%

SCPB using dexamethasone 2 mg in 10 ml of bupivacaine 0.25%

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Sahar MM El-Shall, M.D. · Professor of Anesthesiology, Surgical ICU & Pain Management, Cairo University

  • Mohsen M Waheb, M.D. · Lecturer of Anesthesiology, Surgical ICU & Pain Management, Cairo University

  • Kareem MA Nawwar, M.D. · Lecturer of Anesthesiology, Surgical ICU & Pain Management, Cairo University

  • Aboumazen A Abouhashem, M.B.B.Ch. · Resident of Anesthesia, Surgical ICU & Pain Management

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2024-06-30
Completion
2024-07-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06416891 on ClinicalTrials.gov